The Centre for the Commercialization of Antibodies and Biologics (CCAB) announced a license agreement with Empirica Therapeutics Inc. aimed at developing new treatments for one of the deadliest forms of brain cancer, glioblastoma. Glioblastoma (GBM) is an aggressive brain cancer that, even with the best current standard of care – which includes surgery, radiation treatment […]
Feb-2019
EMN, a Hamilton-based medical nutrition company, has raised a $1.2 Million seed round led by several prominent angel investors from the Greater Toronto Area and leading medical device distributors based in Texas and Illinois. “We are thrilled to have strategic investors on board to support our growing commercial operations in North America and Southeast Asia,” […]
As Canada strives to maintain a leadership position in science and technology, the Centre for Probe Development and Commercialization (CPDC), located at McMaster University, has partnered with the Canadian Nuclear Isotope Council (CNIC) to ensure Canada remains at the forefront of medical isotope R&D and production, and to advocate for continued investment to ensure we […]
Feb-2019
A company from Lancaster, England has set up shop in Hamilton with plans of expanding their reach into North America. The City of Hamilton has been working hard to attract international business to the area, and is using community partners as an incentive. Yordas group, a UK based consulting company that helps with risk assessment, […]
The NFL’s path to improve player safety continued Saturday morning at the fourth annual “1st and Future” experience at the Ferst Center for the Arts at the Georgia Tech campus. Player safety awareness, especially concussions, has been a driving theme for the NFL in recent years, and points of emphasis on rules or modifications take […]